Results: 1-25 | 26-37
Results: 1-25/37

Authors: SCHWARTZ MK
Citation: Mk. Schwartz, TUMOR-MARKERS, Journal of clinical ligand assay, 21(1), 1998, pp. 8-9

Authors: MORRIS DL DILLON PW VERY DL NG P KISH L GOLDBLATT JL BRUZEK DJ CHAN DW AHMED MS WITEK D FRITSCHE HA SMITH C SCHWARTZ D SCHWARTZ MK NOTEBOOM JL VESSELLA RL YEUNG KK ALLARD WJ
Citation: Dl. Morris et al., BAYER IMMUNO 1(TM) PSA ASSAY - AN AUTOMATED, ULTRASENSITIVE METHOD TOQUANTITATE TOTAL PSA IN SERUM, Journal of clinical laboratory analysis, 12(1), 1998, pp. 65-74

Authors: CHELI CD MARCUS M LEVINE J ZHOU ZQ ANDERSON PH BANKSON DD BOCK J BODIN S EISEN C SENIOR M SCHWARTZ MK YEUNG KK ALLARD WJ
Citation: Cd. Cheli et al., VARIATION IN THE QUANTITATION OF PROSTATE-SPECIFIC ANTIGEN IN REFERENCE MATERIAL - DIFFERENCES IN COMMERCIAL IMMUNOASSAYS, Clinical chemistry, 44(7), 1998, pp. 1551-1553

Authors: MORRIS DL GOLDBLATT JL BEVERIDGE R CHAN DW FRITSCHE HA SCHWARTZ MK WU A YEUNG KK ALLARD WJ
Citation: Dl. Morris et al., THE BAYER IMMUNO-1(TM)-CA15-3(TM) ASSAY - AN AUTOMATED IMMUNOASSAY FOR THE MANAGEMENT OF BREAST-CANCER PATIENTS, Clinical chemistry, 44, 1998, pp. 160-160

Authors: ALLARD WJ ZHOU Z DAI J VESSELLA RL SCHWARTZ MK CHAN DW YEUNG KK MORRIS DL
Citation: Wj. Allard et al., LONGITUDINAL MONITORING OF PROSTATE-CANCER PATIENTS WITH A NOVEL AUTOMATED IMMUNOASSAY FOR COMPLEXED PSA, Clinical chemistry, 44, 1998, pp. 161-161

Authors: DAI J MORRIS DL NEAMAN IE CARNEY W TENNY D YEUNG KK ALLARD WJ CHAN DW SCHWARTZ MK
Citation: J. Dai et al., CLINICAL UTILITY OF AN AUTOMATED SERUM HER-2 NEU ASSAY IN MONITORING PATIENTS WITH METASTATIC BREAST-CANCER/, Clinical chemistry, 44, 1998, pp. 208-208

Authors: NEAMAN IE ARRIGO L PIERRE YF SMITH C SCHWARTZ MK SHARP T CUNY C SORIANO T VERY DL
Citation: Ie. Neaman et al., EVALUATION OF THE BAYER IMMUNO-1(TM) AFP ASSAY IN NONSEMINOMATOUS TESTICULAR CANCER, Clinical chemistry, 44, 1998, pp. 210-210

Authors: CHELI CD MORRIS DL KISH L GOLDBLATT J NEAMAN I ALLARD WJ YEUNG KK WU AHB MOORE R CHAN DW FRITSCHE HA SCHWARTZ MK VERY DL
Citation: Cd. Cheli et al., MULTICENTER EVALUATION OF THE BAYER IMMUNO I(TM) CA 15-3(TM) ASSAY, Clinical chemistry, 44(4), 1998, pp. 765-772

Authors: SCHWARTZ MK
Citation: Mk. Schwartz, A PRAGMATIC REVIEW OF TUMOR-MARKERS RISK ASSESSMENT ANALYSIS (SCREENING), Journal of clinical ligand assay, 20(1), 1997, pp. 152-154

Authors: SMITH C SCHWARTZ MK DNISTRIAN A HUDIS C SCHWARTZ DL MORRIS D
Citation: C. Smith et al., EVALUATION OF THE CA15-3(TM) ASSAY (BREAST-CANCER MARKER) ON THE TECHNICON IMMUNO-1(R) SYSTEM, Clinical chemistry, 43, 1997, pp. 599-599

Authors: SCHWARTZ MK SMITH C DNISTRIAN A FLEISHER M SCHWARTZ D NEAMAN I
Citation: Mk. Schwartz et al., ALPHA-FETOPROTEIN (AFP) AND CHORIONIC-GONADOTROPIN (HCG) ASSAYED SIMULTANEOUSLY BY THE TECHNICON IMMUNO-1(R) SYSTEM IN THE SERUM OF MEN WITH TESTICULAR CANCER, Clinical chemistry, 43, 1997, pp. 602-602

Authors: DNISTRIAN AM SCHWARTZ MK GREENBERG EJ SMITH CA SCHWARTZ DC MAIMONIS P
Citation: Am. Dnistrian et al., EVALUATION OF A BREAST-CANCER ANTIGEN ASSAYED ON THE CIBA-CORNING ACS180(R) AUTOMATED CHEMILUMINESCENCE SYSTEM/, Journal of tumor marker oncology, 11(3), 1996, pp. 5-10

Authors: MORRIS DL DILLON P CHAN DW FRITSCHE HA SCHWARTZ MK VESSELLA RL YEUNG KK ALLARD WJ
Citation: Dl. Morris et al., TECHNICON-IMMUNO-1(R) PROSTATE-SPECIFIC ANTIGEN (PSA) ASSAY IS PRECISE, ULTRASENSITIVE AND INSENSITIVE TO COMPLEXATION OF PSA, Clinical chemistry, 42(6), 1996, pp. 98-98

Authors: SMITH C SCHWARTZ MK SCHWARTZ D DNISTRIAN A
Citation: C. Smith et al., TOTAL PROSTATE-SPECIFIC ANTIGEN (TPSA) ASSAYED ON THE DELPHIA (WALLACOY) IMMUNODIAGNOSTIC SYSTEM, Clinical chemistry, 42(6), 1996, pp. 685-685

Authors: SCHWARTZ MK SMITH C SCHWARTZ D DNISTRIAN A FAIR W FLESHNER N SCHER H
Citation: Mk. Schwartz et al., EVALUATION OF THE HYBRITECH-FREE (PSA-F) AND TOTAL PSA (PSA-T), Clinical chemistry, 42(6), 1996, pp. 686-686

Authors: FLEISHER M SEPKOVIC D BRADLOW HL SCHWARTZ MK
Citation: M. Fleisher et al., ESTROGEN METABOLITE RATIOS AS BIOMARKERS OF HORMONALLY RELATED BREAST-CANCER RISK, Clinical chemistry, 42(6), 1996, pp. 689-689

Authors: MENENDEZBOTET CJ CELUCIA F DORSA R SCHWARTZ MK
Citation: Cj. Menendezbotet et al., MANAGEMENT PROGRAM FOR BEDSIDE BLOOD-GLUCOSE MONITORING, Clinical chemistry, 42(6), 1996, pp. 727-727

Authors: YOUNG DS DIAMANDIS E BOHUON C SIEST G BUTTNER JS LAUE D SIEKMANN L ANAGNOSTOUCACARAS E SPANOS E SALVATORE F OKUDA K WHITEHEAD TP APPLE FS ASH KO BOWIE LJ BRUNS DE DEMERS LM DOUMAS BT GALLWAS GE GARBER CC HICKS JM LADENSON JH MCDONALD JM RODGERSON DO SCHWARTZ MK TIETZ NW VALDES R WEINERT H WERNER M
Citation: Ds. Young et al., THE FUTURE OF CLINICAL-CHEMISTRY AND ITS ROLE IN HEALTH-CARE - A REPORT OF THE ATHENA-SOCIETY, Clinical chemistry, 42(1), 1996, pp. 96-101

Authors: JAIN A MEHTA T AULD PAM RODRIGUES J WARD RF SCHWARTZ MK MARTENSSON J
Citation: A. Jain et al., GLUTATHIONE METABOLISM IN NEWBORNS - EVIDENCE FOR GLUTATHIONE DEFICIENCY IN PLASMA, BRONCHOALVEOLAR LAVAGE FLUID, AND LYMPHOCYTES IN PREMATURES, Pediatric pulmonology, 20(3), 1995, pp. 160-166

Authors: DNISTRIAN AM SCHWARTZ MK GREENBERG EJ SCHWARTZ DC
Citation: Am. Dnistrian et al., BR27.29 AS A MARKER IN BREAST-CANCER, Journal of tumor marker oncology, 10(4), 1995, pp. 91-97

Authors: SCHWARTZ MK
Citation: Mk. Schwartz, ACUTE-PHASE REACTANTS ITS TUMOR-MARKERS, Cancer investigation, 13(4), 1995, pp. 444-445

Authors: SCHWARTZ MK
Citation: Mk. Schwartz, CURRENT STATUS OF TUMOR-MARKERS, Scandinavian journal of clinical & laboratory investigation, 55, 1995, pp. 5-14

Authors: JAIN A MADSEN DC AULD PAM FRAYER WW SCHWARTZ MK MEISTER A MARTENSSON J
Citation: A. Jain et al., L-2-OXOTHIAZOLIDINE-4-CARBOXYLATE, A CYSTEINE PRECURSOR, STIMULATES GROWTH AND NORMALIZES TISSUE GLUTATHIONE CONCENTRATIONS IN RATS FED A SULFUR AMINO ACID-DEFICIENT DIET, The Journal of nutrition, 125(4), 1995, pp. 851-856

Authors: FLEISHER M EISEN C SCHWARTZ MK
Citation: M. Fleisher et al., A METHOD COMPARISON OF HEMOGLOBIN-A1(C) BY TURBIDIMETRIC INHIBITION IMMUNOASSAY AND ION-EXCHANGE, Clinical chemistry, 41(6), 1995, pp. 100-100

Authors: MENENDEZBOTET CJ CELUCIA F DORSA R SCHWARTZ MK
Citation: Cj. Menendezbotet et al., PARITY COMPARISON OF LITHIUM, CALCIUM, MAGNESIUM, ZINC AND COPPER BETWEEN THE ATOMIC-ABSORPTION (PERKIN ELMER), DAX (TECHNICON), CX7 (BECKMAN) AND COBAS BIO (ROCHE), Clinical chemistry, 41(6), 1995, pp. 214-214
Risultati: 1-25 | 26-37